Efficacy and Safety of Optimal Muscle Tension Management During Laparoscopic Cholecystectomy
NCT ID: NCT04165057
Last Updated: 2019-11-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
70 participants
INTERVENTIONAL
2020-01-01
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Recovery Under Low or Standard Pneumoperitoneum Pressure
NCT05040022
Comparison Epidural Anesthesia and General Anesthesia in Laparoscopic Cholecystectomy
NCT01398683
Optimizing Pain Management Following Laparoscopic Cholecystectomy RCT
NCT05214157
Low-pressure vs Standard-pressure in Laparoscopic Cholecystectomy
NCT04146090
Comparison of the Efficacy and Safety of NALDEBAIN With Conventional Treatment After Laparoscopic Cholecystectomy
NCT03713216
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group OMT
Optimal muscle tension management
Optimal muscle tension management
including TOF monitor and reversal of neuromuscular blockade agent : sugammadex
Group Control
Conventional anesthetic management
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Optimal muscle tension management
including TOF monitor and reversal of neuromuscular blockade agent : sugammadex
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA score : 1-2
* Regular laparoscopic cholecystectomy
Exclusion Criteria
* BMI \< 18.5 kg/m2 or \>30 kg/m2
* History of other abdominal surgery
* Allergy to rocuronium, cisatracurium, neostigmine or sugammadex
* Emergent surgery
* Convert to open cholecystectomy
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital Hsin-Chu Branch
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MING-HUI HUNG, MD
Role: STUDY_DIRECTOR
National Taiwan University Hospital Hsinchu Branch
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University Hospital, Hsin-Chu Branch
Hsinchu, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
108-084-F
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.